Looking to buy the report?


Diarrhea is a bowel movement (stool) that is loose and watery. It is one of the common, non-serious conditions and can be treated with over-the-counter medicines. Numerous people experience diarrhea once or twice a year.

It is estimated that globally, approximately 2 billion cases of diarrheal diseases occur each year, and about 1.9 million children (below five years of age), mostly found in developing countries, die from diarrhea. All these factors are contributing and showing the impact of diabetic nephropathy across the world.

Report Coverage

This report by Mordor Intelligence provides extensive insights of the current scenario and growth prospects of the market studied. Detailed graphical representations of the pipeline landscape, based on various phases and status of clinical trials, across major regions of the world, are provided, with data obtained from multiple sources. The report also comprises of a list of key sponsors, having pipeline products for the concerned market.

Diarrhea Clinical Trial Analysis by Phase and Status

  • The clinical trial analysis for diarrhea indicates that there are around XX number of trials under various phases
  • Phase X trials accounted for the majority share
  • The trial data analysis suggests number of ongoing trials and ones terminated

Diarrhea Clinical Trials Analysis, by Geography

  • By geography, the scope of the report covers the regional assessment for the clinical trials, globally. It covers a concise information of registered clinical trials in different countries across several developed and emerging markets
  • The number of people suffering with diarrhea is rising, and this is one of the driving factors for the market. According to the WHO, diarrhea kills around 525, 000 children under five years of age every year. As per the CDC, diarrheal diseases account for one in nine child deaths worldwide, making diarrhea the second leading cause of death among children under the age of five years

Key Sponsors in Diarrhea Clinical Trials

The report will cover analysis on trails and information on key sponsors, companies, and researchers.

Research Methodology

Our data collection team builds scientific research models, based on data sourced from various internal databases, primary and secondary researches, and in-house team of research experts. The pipeline assessment reports are generated based on information procured from various stake holders, such as sponsors, clinical trial organizations, pharmaceutical companies, government bodies, trade agencies, industry journals, scientific literature databases, investor reports, press release statements, and several other sources. The data generated using secondary and primary research are validated through discussions with industry KOL’s and C-suite executives. The data presented in the reports are continuously updated to incorporate the most relevant and authentic information to our clients.

Reasons to buy the Report

This report will help you to understand

  • The number of clinical trials being conducted worldwide
  • The key products that are under development (Phase 0, Phase I, Phase II, and Phase III)
  • The main area of research under development (by product, mechanism of action, molecule, delivery, etc.)
  • The average recruitment size in trials
  • Key deals between institutions and industries
  • Gather insights on regional and country-level data
  • Review of dormant and discontinued studies across the category
  • Information on key sponsors and profiles
  • Protocol and design comparisons to generate the best solution for your product  development strategy

1. Introduction

2. Research Methodology

3. Disease Epidemiology and Trends

4. Healthcare Expenditure and R&D Trends

5. Executive Summary

6. Clinical Trials Segmentation- by Phase

                6.1 Phase III Product Candidates

                6.2 Phase II Product Candidates

                6.3 Phase I Product Candidates

7. Clinical Trials, Segmentation by Status

                7.1 Suspended

                7.2 Terminated

                7.3 Withdrawn

                7.4 Ongoing

                7.5 Completed

                7.6 Other Statuses

8. Pipeline Therapeutic Assessment (Info graphic Charts and Brief description)

                8.1. By Clinical Phase and Molecule Type

                8.2. By Clinical Phase and Route of Administration

                8.3 By Sponsor/Collaborator/Institutions

                8.4 By Geography

9. Market Updates

10. Key Sponsor Profiles

11. Sources and Disclaimer

12. About Mordor Intelligence

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?



By submitting, you confirm that you agree to our privacy policy